Navigating Global Regulatory Challenges in Pharma: 2025 and Beyond

The pharmaceutical industry is one of the most regulated industries in the world. The regulatory environment is changing rapidly as we approach 2026 due to progress in drug development, changes in digital health technologies, and other implications of geopolitical changes. Companies must deal with intricate compliance obligations, global interoperability, and emerging trends in their regulated […]
Trump’s Pharma Tariffs: Risks, Impact & Strategy

This is not a recent development; it started with the end of Trump’s first term. During the last quarter, executive orders were issued to cut down the costs of medicines. However, the federal court dismissed the motion, citing that this motion didn’t involve public opinion. The Biden administration also attempted it with the IRA when […]